Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
Northern Lights
Mother's Day
Baseball
Donald Trump
Joe Biden
US Politics
Soccer
Republican Party
US Social Issues
Golf
US Crime
Get access to our best features
Get Started
Published 1 month ago

Lupin, Glenmark Recall Drugs In U.S. Market After Regulator's Order

Summary by NDTV Profit
Leading generic drug makers Lupin Ltd., Glenmark Plc, and Natco Pharma Ltd. are recalling products in the American market for manufacturing issues, according to the US health regulator. As per the latest Enforcement Report by the US Food and Drug Administration, Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an antibiotic medication in the US market.The affected lot has been produced by the drug firm at its Aurangabad-based fac…

0 Articles

All
Left
Center
Right
NDTV ProfitNDTV Profit

Lupin, Glenmark Recall Drugs In U.S. Market After Regulator's Order

Leading generic drug makers Lupin Ltd., Glenmark Plc, and Natco Pharma Ltd. are recalling products in the American market for manufacturing issues, according to the US health regulator. As per the latest Enforcement Report by the US Food and Drug Administration, Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an antibiotic medication in the US market.The affected lot has been produced by the drug firm at its Aurangabad-based fac…

1 month ago
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Aurangabad, IndiaAurangabad, India
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal